Pharmaceutical Outsourcing

View online

Forward to a friend | Facebook | Twitter

October 18, 2018

Newsletter Sponsor

Metrics Contract Services Continues Strong Focus on FTIM and Phase I Services

For over 20 years, Metrics has been growing and expanding capacities, capabilities, and manufacturing processes for small molecule oral solid dosage forms. Today we want to remind our clients and the industry that we have not lost our focus on where it all began. Metrics continues to invest in equipment and resources to support a healthy foundation of business in the First-time-in-Man/Phase I space. Visit metricscontractservices.com and learn more about how we can support your next project.

	Industry News

Oracle Acquires goBalto

BioMarin Receives Milestone Payments from Pfizer for Talzenna

IQVIA’s Commercial Technology Suite Selected by Roche

Charles River Awarded Five-Year Contract by NIAID

MWI Animal Health Acquires Software Solutions Provider ALLYDVM

Quotient Sciences Constructs Early-Phase Formulation, Manufacturing Facility

	Featured Articles

HORIZON LINES: A Quarterly Review of NDAs – April-June, 2018 HORIZON LINES: A Quarterly Review of NDAs – April-June, 2018 This quarterly review on New Drug Applications (NDAs) contain data for applications approved for the first time during the second quarter of 2018, which includes New Molecular Entities (NMEs) and new ... read more »

CPhI Annual Report 2018: ADCs Growth Driven by Lack of In-House Facilities, Oncology and Integrated CDMOs CPhI Annual Report 2018: ADCs Growth Driven by Lack of In-House Facilities, Oncology and Integrated CDMOs The past decade has seen significant advances in new cancer treatments through the development of highly selective small molecules that target a specific abnormality responsible for the disease. ... read more »

	Featured Video

Watch Video: Pyramid Laboratories Facility Tour
Watch Video: Pyramid Laboratories Facility Tour
PYRAMID Laboratories, Inc. is a CDMO, focused on parenteral drug products, that offers comprehensive pipeline of services to pharmaceutical and biotech companies. read more »

Watch Video: A Discussion with Dr. Thomas Page, VP Engineering and Asset Development at Fujifilm Diosynth Biotechnologies
A Discussion with Dr. Thomas Page, VP Engineering and Asset Development at Fujifilm Diosynth Biotechnologies
Watch Video: A Discussion with Dr. Thomas Page, VP Engineering and Asset Development at Fujifilm Diosynth Biotechnologies read more »

	Featured Whitepaper

Support of Scale-Up and Technical Transfer Through Understanding Equipment for Lyophilization Support of Scale-Up and Technical Transfer Through Understanding Equipment for Lyophilization Formulation and process development for injectable products are typically conducted at laboratory-scale. read more »

Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multi-Product Facility Manufacturing of Cytotoxic and Non-Cytotoxic Drugs in a Multi-Product Facility Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less ... read more »

	Events

7th Pharmaceutical Traceability Forum
Philadelphia, PA – 11/28/2018
Time's up! For pharma manufacturers, the deadline for DSCSA serialization compliance in the US is well and truly here. The good news: most companies ... event details »

CPhI India 2018
Delhi, India – 12/12/2018
Open-up to the Indian market! As the pharma industry is increasingly looking towards India for high quality, low cost pharma solutions, CPhI & P-... event details »

This information is being brought to you because you are a subscriber to
Pharmaceutical Outsourcing.

To ensure delivery to your inbox,
please add newsletters@pharmoutsourcing.com to your address book.

Manage your Subscription | Unsubscribe | Contact Pharmaceutical Outsourcing

Pharmaceutical Outsourcing
164 Townsend St. Unit 2
San Francisco, CA 94107 USA